News & events

E.coli samples News article 22 Nov 2023 New research aims to prevent transmission of enteric bacteria and tackle antimicrobial resistance From: LSTM New research seeks to better understand where and how Escherichia coli is acquired, enabling more effective interventions to prevent transmission and...
Plaque assays which are done to quantify virus infectivity News article 11 Oct 2023 Molecular compound does not generate antiviral response to COVID infection, study shows From: LSTM A type of drug that had been suggested as a potential COVID-19 treatment may not be clinically useful, a study led by Liverpool School of Tropical...
News article 19 Jul 2023 Search for effective CCHF Treatments: first patient dosed in novel clinical trial platform in Turkiye From: LSTM July 18th 2023 –Liverpool School of Tropical Medicine (LSTM) and Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital in Ankara...
News article 13 Mar 2023 A large LSTM-led trial confirms new antimalarial, dihydroartemisinin-piperaquine, is more effective at preventing malaria than current WHO recommended treatment but does not improve adverse birth outcomes. From: LSTM A large multi-country trial of 4680 women in sub-Sahara Africa, looking at new antimalarial treatment for pregnant women in Africa, led by Prof....
News article 2 Feb 2023 Liverpool School of Tropical Medicine awarded £4.7 million to establish a new Human Challenge Facility, for infectious disease research From: LSTM LiverpoolSchool of Tropical Medicine (LSTM) is celebrating being awarded £4.7 million in funding from the Research England Development (RED) Fund....
News article 5 Jan 2023 LSTM and MLW researchers part of team calling for simpler diagnostic tools for chronic hepatitis B patients in Africa From: LSTM A group of international researchers, including those from Liverpool School of Tropical Medicine (LSTM) and the Malawi Liverpool Welcome Trust (MLW...
News article 21 Jun 2022 Ivermectin for COVID-19 review update: 11 trials and no evidence of benefit shown From: LSTM There remains no evidence to support the use of ivermectin for treating or preventing COVID-19 infection, state the authors of an updated Cochrane...
iiCON has supported 11 new products to market in 18 months News article 6 May 2022 iiCON supports 11 new products to market in first 18 months From: LSTM The LSTM-led consortium, iiCON: Infection Innovation Consortium, has supported 11 new products to market since launching in September 2020, with a...